Tumor Boards

Program overview and session management

Breast Oncology Tumor Board

Breast Oncology · Tuesdays 07:30 · hybrid

AF

MC

PH

LW

RG

AR

+6

12 core members · Avg. attendance: 11.4

Next Session

Sat, May 2

20 cases queued·15 ready·1 blocked

Ibrahim, Arthur — Lab results pending

Last session Sat, Apr 18 · 0 attendees

90%

Closure

10.6d

Avg Action

288

Open

Closure trend

Recently Discussed

O'Brien, Margaret

Invasive Lobular Carcinoma

Washington, Aaliyah

Ductal Carcinoma In Situ (DCIS)

Chang, Dorothy

Invasive Ductal Carcinoma

Sharma, Priya

Invasive Ductal Carcinoma

GI Oncology Tumor Board

GI Oncology · Wednesdays 12:00 · in-person

JW

SM

DP

MO

KL

TN

+4

10 core members · Avg. attendance: 9.5

Next Session

Sun, May 3

22 cases queued·16 ready·1 blocked

Martinez, Rosa — Lab results pending

Last session Sun, Apr 12 · 11 attendees

87%

Closure

13.8d

Avg Action

386

Open

Closure trend

Recently Discussed

Adeyemi, Christopher

Esophageal Adenocarcinoma

Martinez, Rosa

Rectal Adenocarcinoma

Greene, Harold

Hepatocellular Carcinoma

Al-Rashid, Fatima

Intrahepatic Cholangiocarcinoma

Thoracic Oncology Tumor Board

Thoracic Oncology · Thursdays 08:00 · hybrid

KL

RK

AR

PH

MO

TN

+5

11 core members · Avg. attendance: 7.4

Next Session

Mon, May 4

18 cases queued·13 ready·1 blocked

Rao, Maria — Lab results pending

Last session Mon, Apr 13 · 6 attendees

90%

Closure

10.7d

Avg Action

144

Open

Closure trend

Recently Discussed

Kim, Barbara

Non-Small Cell Lung Cancer

Torres, William

Non-Small Cell Lung Cancer

Okafor, Raymond

Malignant Pleural Mesothelioma

Campbell, Angela

Non-Small Cell Lung Cancer

Cross-Board Comparison

Metric	Breast	GI	Thoracic
Cases Reviewed	319	213	206
Avg / Session	11.0	7.6	7.4
Closure Rate	90%	87%	90%
Avg Days to Action	10.6	13.8	10.7
Avg Attendance	11.4	9.5	7.4
Open Recommendations	288	386	144